(Q36800837)

16 August 2017

Management of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspective (English)

1 reference

16 August 2017

1 reference

Ravindra S Date

1

1 reference

16 August 2017

Nicholas A Stylianides

2

1 reference

16 August 2017

Kishore G Pursnani

3

1 reference

16 August 2017

Jeremy B Ward

4

1 reference

16 August 2017

Muntzer M Mughal

5

1 reference

16 August 2017

18 July 2008

1 reference

World Journal of Surgical Oncology

16 August 2017

1 reference

16 August 2017

6

1 reference

16 August 2017

77

1 reference

Creative Commons Attribution 2.0 Generic

16 August 2017

start time

18 July 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1477-7819-6-77

0 references

cites work

Endoscopic enucleation of gastrointestinal stromal tumors of the stomach: report of five cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Gastrointestinal stromal tumours: clinical overview, surgery and recent advances in imatinib mesylate therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2491627

Myosarcomas of the stomach: natural history, prognostic factors and management

5 September 2018

1 reference

12 December 2020

Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging

1 reference

12 December 2020

Surgical resection of gastrointestinal stromal tumors after treatment with imatinib

1 reference

12 December 2020

Laparoscopic wedge resection for gastric GIST: long-term follow-up results

1 reference

12 December 2020

Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor

1 reference

12 December 2020

Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection

1 reference

12 December 2020

Prognostic factors for primary GIST: prime time for personalized therapy?

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7819-6-77

1 reference

Dimensions Publication ID

16 August 2017

1006951205

0 references

Fatcat ID

release_ryeyeo626zcpxd72o3zpnkd7mq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ryeyeo626zcpxd72o3zpnkd7mq

24 November 2022

mapped directly with Wikidata item

1 reference

16 August 2017

PubMed publication ID

18644105

1 reference